Literature DB >> 28923528

Arterial spin labeling hyperperfusion in Rasmussen's encephalitis: Is it due to focal brain inflammation or a postictal phenomenon?

Savith Kumar1, Chinmay P Nagesh2, Bejoy Thomas3, Ashalatha Radhakrishnan4, Ramshekhar N Menon5, Chandrasekharan Kesavadas6.   

Abstract

BACKGROUND AND
PURPOSE: The study evaluated the utility of arterial spin labeling (ASL) perfusion imaging in Rasmussen's encephalitis (RE).
MATERIAL AND METHODS: The hospital electronic database was searched using the search words "encephalitis," "autoimmune encephalitis" and "Rasmussen's encephalitis" for the period of 1 Jan 2015 to 31 Jan 2017. Clinically diagnosed cases of RE for which epilepsy protocol magnetic resonance imaging (MRI) with perfusion imaging (ASL) performed on a 3T scanner were retrieved. The diagnosis of RE was based on Bien's criteria (Bien et al., 2005). We obtained patient's demographic details, clinical features, electrophysiological studies, and follow-up data from electronic hospital records.
RESULTS: We included nine patients with RE of whom seven patients showed increased perfusion, and two patients decreased perfusion. Among these patients, MRI changes of gyral hyperintensity without volume loss corresponded to regional ASL hyperperfusion in six patients and ASL hypoperfusion in one patient. Two patients who showed ASL hypoperfusion had corresponding atrophy on MRI. Eight patients of RE had epilepsia partialis continua (EPC) or daily seizures, and one patient was seizure-free post-surgery. Five patients showed a concordance of ASL hyperperfusion with clinical ictal onset zone. Among the seven patients with ASL hyperperfusion, the finding was concordant (complete or partial) with the electroencephalogram (EEG) ictal onset zone in six patients and with interictal epileptiform discharges (IED) in seven patients.
CONCLUSION: Increased perfusion in ASL of the involved brain parenchyma in RE is a common MRI finding and may be due to either active inflammation of the brain involved or a seizure-related finding.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Arterial spin labeling; Autoimmune encephalitis; Encephalitis; Rasmussen's encephalitis

Mesh:

Substances:

Year:  2017        PMID: 28923528     DOI: 10.1016/j.neurad.2017.08.002

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  5 in total

1.  Arterial spin-labeling perfusion imaging of childhood encephalitis: correlation with seizure and clinical outcome.

Authors:  Alex Mun-Ching Wong; Chih-Hua Yeh; Jainn-Jim Lin; Ho-Ling Liu; I-Jun Chou; Kuang-Lin Lin; Huei-Shyong Wang
Journal:  Neuroradiology       Date:  2018-07-25       Impact factor: 2.804

2.  Clinical utility of arterial spin labeling perfusion images in the emergency department for the work-up of stroke-like symptoms.

Authors:  Karen Buch; Reza Hakimelahi; Joseph J Locascio; Divya S Bolar; R Giliberto Gonzalez; Pamela W Schaefer
Journal:  Neuroradiology       Date:  2021-10-18       Impact factor: 2.804

3.  Regarding "Brain Perfusion Alterations on 3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in Patients with Autoimmune Encephalitis: A Case Series and Literature Review".

Authors:  X Zhang; D Zheng; Q Huang
Journal:  AJNR Am J Neuroradiol       Date:  2022-08-25       Impact factor: 4.966

4.  Effect of blood T1 estimation strategy on arterial spin labeled cerebral blood flow quantification in children and young adults with kidney disease.

Authors:  Hua-Shan Liu; Abbas F Jawad; Nina Laney; Erum A Hartung; Susan L Furth; John A Detre
Journal:  J Neuroradiol       Date:  2018-03-28       Impact factor: 3.447

5.  The Imaging of Localization Related Symptomatic Epilepsies: The Value of Arterial Spin Labelling Based Magnetic Resonance Perfusion.

Authors:  Chinmay Nagesh; Savith Kumar; Ramshekhar Menon; Bejoy Thomas; Ashalatha Radhakrishnan; Chandrasekharan Kesavadas
Journal:  Korean J Radiol       Date:  2018-08-06       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.